Company intelligence / Profile preview

Miromatrix Medical

Eden Prairie, Minnesota, United Statesmiromatrix.com ↗

Ownership: Public · MIRO
Development stage: Other

Overview

Miromatrix has demonstrated extensive preclinical proof-of-concept in large animal models for its bioengineered organs. The company received FDA IND clearance to begin clinical investigation of miroliver ELAP®, a bioengineered external liver assist device. Other programs remain in the preclinical stage.

Therapeutic areas: GastroenterologyCardiovascularNephrology
Modalities: Cell therapyBiologicDevice
Industry: Biotech

Drug pipeline

1 asset

miroliverELAP

Unknown

Partnerships

BaxterCareDxMayo ClinicMount Sinai HospitalTexas Heart Institute

Beyond the preview

Go deeper on Miromatrix Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Miromatrix Medical.

Explore the full profile